Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry

Kabasakal, Levent; Toklu, Turkay; Yeyin, Nami; Demirci, Emre; Abuqbeitah, Mohammad; Ocak, Emine; Aygun, Aslan; Karayel, Emre; Pehlivanoglu, Huseyin; Selcuk, Nalan

doi:10.4274/mirt.08760

Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry

Atıf İçin Kopyala

Kabasakal L., Toklu T., Yeyin N., Demirci E. , Abuqbeitah M., Ocak M. , ...Daha Fazla

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.26, sa.2, ss.62-68, 2017 (ESCI İndekslerine Giren Dergi)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 26 Konu: 2
Basım Tarihi: 2017
Doi Numarası: 10.4274/mirt.08760
Dergi Adı: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
Sayfa Sayıları: ss.62-68

Özet

Objective: The aim of the study was to estimate the radiation-absorbed doses and to study the in vivo and in vitro stability as well as pharmacokinetic characteristics of lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA)-617.